ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Rassi A Jr, Rassi A, Marin-Neto JA, 2010. Chagas disease. Lancet 375: 1388–1402.
-
2.
Sabino EC, Riberio AL, Salemi VM, Di Lorenzo Oliveria C, Antunes AP, Menezez MM, Ianni BM, Nastari L, Fernandes F, Patavino GM, Sachdev V, Capuani L, de Almeida-Neto C, Carrick DM, Wright D, Kavounis K, Goncalez TT, Carneiro-Proietti AB, Custer B, Busch MP, Murphy EL; National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study-II (REDS-II), International Component, 2013. Ten-year incidence of Chagas cardiomyopathy among asymptomatic Trypanosoma cruzi-seropositive former blood donors. Circulation 127: 1105–1115.
-
3.
Jackson Y, Chatelain E, Mauris A, Holst M, Miao Q, Chappuis F, 2013. Serological and parasitological response in chronic Chagas patients 3 years after nifurtimox treatment. BMC Infect Dis 13: 85.
-
4.
Pinazo MJ, Munoz J, Posada E, Lopez-Chejade P, Gallego M, Ayala E, del Cacho E, Soy D, Gascon J, 2010. Tolerance of benznidazole in treatment of Chagas disease in adults. Antimicrob Agents Chemother 54: 4896–4899.
-
5.
Kirchhoff LV, 1993. American trypanosomiasis (Chagas' disease)—a tropical disease now in the United States. N Engl J Med 329: 639–644.
-
6.
Sarkar S, Strutz SE, Frank DM, Rivaldi CL, Sissel B, Sanchez-Cordero V, 2010. Chagas disease risk in Texas. PLOS NTDs 4: e836.
-
7.
Kjos SA, Marcet PL, Yabsley MJ, Kitron U, Snowden KF, Logan KS, Barnes JC, Doston EM, 2013. Identification of bloodmeal sources and Trypanosoma cruzi infection in triatomine bugs (Hemiptera: Reduviidae) from residential settings in Texas, the United States. J Med Entomol 50: 1126–1139.
-
8.
Woody NC, Woody HB, 1955. American trypanosomiasis (Chagas' disease); first indigenous case in the United States. JAMA 159: 676–677.
-
9.
Beard CB, Pye G, Steurer FJ, Rodriguez R, Campman R, Peterson AT, Ramsey J, Wirtz RA, Robinson LE, 2003. Chagas disease in a domestic transmission cycle, southern Texas, USA. Emerg Infect Dis 9: 103–105.
-
10.
Garcia MN, Woc-Colburn L, Rossmann SN, Townsend RL, Stramer SL, Bravo M, Kamel H, Beddard R, Townsend M, Oldham R, Bottazzi ME, Hotez PJ, Murray KO, 2014. Trypanosoma cruzi screening in Texas blood donors, 2008–2012. Epidemiol Infect. doi:http://dx.doi.org/10.1017/S0950268814002234. Published online: 28 August 2014.
-
11.
Texas Department of State Health Services, 2014. Texas Notifiable Conditions. Available at: http://www.dshs.state.tx.us/idcu/investigation/conditions/contacts/. Accessed March 25, 2014.
-
12.
Cantey PT, Stramer SL, Townsend RL, Kamel H, Ofafa K, Todd CW, Currier M, Hand S, Varnado W, Dotson E, Hall C, Jett PL, Montgomery SP, 2012. The United States Trypanosoma cruzi infection study: evidence for vector-borne transmission of the parasite that causes Chagas disease among United States blood donors. Transfusion 52: 1922–1930.
-
13.
Bern C, Montogomery SP, 2009. An estimate of the burden of Chagas disease. Clin Infect Dis 49: e52–e54.
-
14.
Garcia MN, Murray KO, Hotez PJ, Rossmann SN, Gorchakov R, Ontiveros A, Woc-Colburn L, Bottazzi ME, Rhodes CE, Ballantyne CM, Aguilar D, 2014. Development of Chagas cardiac manifestations among Texas blood donors. Am J Cardiol 115: 113–117.
-
15.
Custer B, Agapova M, Bruhn R, Cusick R, Kamel H, Tomasulo P, Biswas H, Tobler L, Lee TH, Caglioti S, Busch M, 2012. Epidemiologic and laboratory findings from 3 years of testing United States blood donors for Trypanosoma cruzi. Transfusion 52: 1901–1911.
-
16.
Wilson LS, Ramsey JM, Koplowicz YB, Valiente-Banuet L, Motter C, Bertozzi SM, Tobler LH, 2008. Cost-effectiveness of implementation methods for ELISA serology testing of Trypanosoma cruzi in California blood banks. Am J Trop Med Hyg 79: 53–68.
-
17.
Leiby DA, Read EJ, Lenes BA, Yund AJ, Stumpf RJ, Kirchhoff LV, Dodd RY, 1997. Seroepidemiology of Trypanosoma cruzi, etiologic agent of Chagas disease, in US blood donors. J Infect Dis 176: 1047–1052.
-
18.
O'Brien SF, Chiavetta JA, Fan W, Xi G, Yi QL, Goldman M, Scalia V, Fearon MA, 2008. Assessment of a travel question to identify donors with risk of Trypanosoma cruzi: operational validity and field testing. Transfusion 48: 755–761.
-
19.
Garcia MN, Hotez PJ, Murray KO, 2014. Potential novel risk factors for autochthonous and sylvatic transmission of human Chagas disease in the United States. Parasit Vectors 7: 311.
-
20.
Edwards MS, Rench MA, Todd CW, Czaicki N, Steurer FJ, Bern C, Montgomery SP, 2013. Perinatal screening for Chagas disease in southern Texas. J Ped Infect Dis 1–4. Available at: http://jpids.oxfordjournals.org/content/early/2013/10/03/jpids.pit056.1.full.pdf+html?sid=f876a11f-40f5-44d5-91e0-219c6e0f257f.
-
21.
Di Pentima MC, Hwang LY, Skeeter CM, Edwards MS, 1999. Prevalence of antibody to Trypanosoma cruzi in pregnant Hispanic women in Houston. Clin Infect Dis 28: 1281–1285.
-
22.
Stimpert KK, Montgomery SP, 2010. Physician awareness of Chagas disease, USA. Emerg Infect Dis 16: 871–872.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 1162 | 887 | 31 |
| Full Text Views | 652 | 15 | 0 |
| PDF Downloads | 239 | 14 | 0 |
Evidence of Autochthonous Chagas Disease in Southeastern Texas
Melissa N. Garcia
Melissa N. Garcia
Baylor College of Medicine, National School of Tropical Medicine, Section of Tropical Medicine, Houston, Texas; Baylor College of Medicine, Department of Medicine, Section of Cardiology, Houston, Texas; Gulf Coast Regional Blood Center, Houston, Texas; United States Centers for Disease Control and Prevention, Division of Parasitic Diseases and Malaria, Atlanta, Georgia
Search for other papers by Melissa N. Garcia in
Current site
Google Scholar
PubMed
Search for other papers by Melissa N. Garcia in
Current site
Google Scholar
PubMed
David Aguilar
David Aguilar
Baylor College of Medicine, National School of Tropical Medicine, Section of Tropical Medicine, Houston, Texas; Baylor College of Medicine, Department of Medicine, Section of Cardiology, Houston, Texas; Gulf Coast Regional Blood Center, Houston, Texas; United States Centers for Disease Control and Prevention, Division of Parasitic Diseases and Malaria, Atlanta, Georgia
Search for other papers by David Aguilar in
Current site
Google Scholar
PubMed
Search for other papers by David Aguilar in
Current site
Google Scholar
PubMed
Rodion Gorchakov
Rodion Gorchakov
Baylor College of Medicine, National School of Tropical Medicine, Section of Tropical Medicine, Houston, Texas; Baylor College of Medicine, Department of Medicine, Section of Cardiology, Houston, Texas; Gulf Coast Regional Blood Center, Houston, Texas; United States Centers for Disease Control and Prevention, Division of Parasitic Diseases and Malaria, Atlanta, Georgia
Search for other papers by Rodion Gorchakov in
Current site
Google Scholar
PubMed
Search for other papers by Rodion Gorchakov in
Current site
Google Scholar
PubMed
Susan N. Rossmann
Susan N. Rossmann
Baylor College of Medicine, National School of Tropical Medicine, Section of Tropical Medicine, Houston, Texas; Baylor College of Medicine, Department of Medicine, Section of Cardiology, Houston, Texas; Gulf Coast Regional Blood Center, Houston, Texas; United States Centers for Disease Control and Prevention, Division of Parasitic Diseases and Malaria, Atlanta, Georgia
Search for other papers by Susan N. Rossmann in
Current site
Google Scholar
PubMed
Search for other papers by Susan N. Rossmann in
Current site
Google Scholar
PubMed
Susan P. Montgomery
Susan P. Montgomery
Baylor College of Medicine, National School of Tropical Medicine, Section of Tropical Medicine, Houston, Texas; Baylor College of Medicine, Department of Medicine, Section of Cardiology, Houston, Texas; Gulf Coast Regional Blood Center, Houston, Texas; United States Centers for Disease Control and Prevention, Division of Parasitic Diseases and Malaria, Atlanta, Georgia
Search for other papers by Susan P. Montgomery in
Current site
Google Scholar
PubMed
Search for other papers by Susan P. Montgomery in
Current site
Google Scholar
PubMed
Hilda Rivera
Hilda Rivera
Baylor College of Medicine, National School of Tropical Medicine, Section of Tropical Medicine, Houston, Texas; Baylor College of Medicine, Department of Medicine, Section of Cardiology, Houston, Texas; Gulf Coast Regional Blood Center, Houston, Texas; United States Centers for Disease Control and Prevention, Division of Parasitic Diseases and Malaria, Atlanta, Georgia
Search for other papers by Hilda Rivera in
Current site
Google Scholar
PubMed
Search for other papers by Hilda Rivera in
Current site
Google Scholar
PubMed
Laila Woc-Colburn
Laila Woc-Colburn
Baylor College of Medicine, National School of Tropical Medicine, Section of Tropical Medicine, Houston, Texas; Baylor College of Medicine, Department of Medicine, Section of Cardiology, Houston, Texas; Gulf Coast Regional Blood Center, Houston, Texas; United States Centers for Disease Control and Prevention, Division of Parasitic Diseases and Malaria, Atlanta, Georgia
Search for other papers by Laila Woc-Colburn in
Current site
Google Scholar
PubMed
Search for other papers by Laila Woc-Colburn in
Current site
Google Scholar
PubMed
Peter J. Hotez
Peter J. Hotez
Baylor College of Medicine, National School of Tropical Medicine, Section of Tropical Medicine, Houston, Texas; Baylor College of Medicine, Department of Medicine, Section of Cardiology, Houston, Texas; Gulf Coast Regional Blood Center, Houston, Texas; United States Centers for Disease Control and Prevention, Division of Parasitic Diseases and Malaria, Atlanta, Georgia
Search for other papers by Peter J. Hotez in
Current site
Google Scholar
PubMed
Search for other papers by Peter J. Hotez in
Current site
Google Scholar
PubMed
Kristy O. Murray
Kristy O. Murray
Baylor College of Medicine, National School of Tropical Medicine, Section of Tropical Medicine, Houston, Texas; Baylor College of Medicine, Department of Medicine, Section of Cardiology, Houston, Texas; Gulf Coast Regional Blood Center, Houston, Texas; United States Centers for Disease Control and Prevention, Division of Parasitic Diseases and Malaria, Atlanta, Georgia
Search for other papers by Kristy O. Murray in
Current site
Google Scholar
PubMed
Search for other papers by Kristy O. Murray in
Current site
Google Scholar
PubMed
Autochthonous transmission of Trypanosoma cruzi in the United States is rarely reported. Here, we describe five newly identified patients with autochthonously acquired infections from a small pilot study of positive blood donors in southeast Texas. Case-patients 1–4 were possibly infected near their residences, which were all in the same region ∼100 miles west of Houston. Case-patient 5 was a young male with considerable exposure from routine outdoor and camping activities associated with a youth civic organization. Only one of the five autochthonous case-patients received anti-parasitic treatment. Our findings suggest an unrecognized risk of human vector-borne transmission in southeast Texas. Education of physicians and public health officials is crucial for identifying the true disease burden and source of infection in Texas.
Author Notes
Financial support: This study was generously funded by an intramural pilot grant from Baylor College of Medicine's Cardiovascular Research Institute.
Authors' addresses: Melissa N. Garcia, Rodion Gorchakov, Peter J. Hotez, and Kristy O. Murray, Baylor College of Medicine, National School of Tropical Medicine, Department of Pediatrics, Section of Tropical Medicine, Houston, TX, E-mails: mnolan@bcm.edu, rodion@bcm.edu, hotez@bcm.edu, and kmurray@bcm.edu. David Aguilar, Baylor College of Medicine, Department of Medicine, Section of Cardiology, Houston, TX, E-mail: daguilar@bcm.edu. Susan N. Rossmann, Gulf Coast Regional Blood Center, Houston, TX, E-mail: srossmann@giveblood.org. Susan P. Montgomery and Hilda Rivera, Centers for Disease Control and Prevention, Division of Parasitic Diseases and Malaria Parasitic Disease, Atlanta, GA, E-mails: zqu6@cdc.gov and igi2@cdc.gov. Laila Woc-Colburn, Baylor College of Medicine, National School of Tropical Medicine, Department of Medicine, Section of Infectious Diseases, Houston, TX, E-mail: lailawoc@gmail.com.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Rassi A Jr, Rassi A, Marin-Neto JA, 2010. Chagas disease. Lancet 375: 1388–1402.
-
2.
Sabino EC, Riberio AL, Salemi VM, Di Lorenzo Oliveria C, Antunes AP, Menezez MM, Ianni BM, Nastari L, Fernandes F, Patavino GM, Sachdev V, Capuani L, de Almeida-Neto C, Carrick DM, Wright D, Kavounis K, Goncalez TT, Carneiro-Proietti AB, Custer B, Busch MP, Murphy EL; National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study-II (REDS-II), International Component, 2013. Ten-year incidence of Chagas cardiomyopathy among asymptomatic Trypanosoma cruzi-seropositive former blood donors. Circulation 127: 1105–1115.
-
3.
Jackson Y, Chatelain E, Mauris A, Holst M, Miao Q, Chappuis F, 2013. Serological and parasitological response in chronic Chagas patients 3 years after nifurtimox treatment. BMC Infect Dis 13: 85.
-
4.
Pinazo MJ, Munoz J, Posada E, Lopez-Chejade P, Gallego M, Ayala E, del Cacho E, Soy D, Gascon J, 2010. Tolerance of benznidazole in treatment of Chagas disease in adults. Antimicrob Agents Chemother 54: 4896–4899.
-
5.
Kirchhoff LV, 1993. American trypanosomiasis (Chagas' disease)—a tropical disease now in the United States. N Engl J Med 329: 639–644.
-
6.
Sarkar S, Strutz SE, Frank DM, Rivaldi CL, Sissel B, Sanchez-Cordero V, 2010. Chagas disease risk in Texas. PLOS NTDs 4: e836.
-
7.
Kjos SA, Marcet PL, Yabsley MJ, Kitron U, Snowden KF, Logan KS, Barnes JC, Doston EM, 2013. Identification of bloodmeal sources and Trypanosoma cruzi infection in triatomine bugs (Hemiptera: Reduviidae) from residential settings in Texas, the United States. J Med Entomol 50: 1126–1139.
-
8.
Woody NC, Woody HB, 1955. American trypanosomiasis (Chagas' disease); first indigenous case in the United States. JAMA 159: 676–677.
-
9.
Beard CB, Pye G, Steurer FJ, Rodriguez R, Campman R, Peterson AT, Ramsey J, Wirtz RA, Robinson LE, 2003. Chagas disease in a domestic transmission cycle, southern Texas, USA. Emerg Infect Dis 9: 103–105.
-
10.
Garcia MN, Woc-Colburn L, Rossmann SN, Townsend RL, Stramer SL, Bravo M, Kamel H, Beddard R, Townsend M, Oldham R, Bottazzi ME, Hotez PJ, Murray KO, 2014. Trypanosoma cruzi screening in Texas blood donors, 2008–2012. Epidemiol Infect. doi:http://dx.doi.org/10.1017/S0950268814002234. Published online: 28 August 2014.
-
11.
Texas Department of State Health Services, 2014. Texas Notifiable Conditions. Available at: http://www.dshs.state.tx.us/idcu/investigation/conditions/contacts/. Accessed March 25, 2014.
-
12.
Cantey PT, Stramer SL, Townsend RL, Kamel H, Ofafa K, Todd CW, Currier M, Hand S, Varnado W, Dotson E, Hall C, Jett PL, Montgomery SP, 2012. The United States Trypanosoma cruzi infection study: evidence for vector-borne transmission of the parasite that causes Chagas disease among United States blood donors. Transfusion 52: 1922–1930.
-
13.
Bern C, Montogomery SP, 2009. An estimate of the burden of Chagas disease. Clin Infect Dis 49: e52–e54.
-
14.
Garcia MN, Murray KO, Hotez PJ, Rossmann SN, Gorchakov R, Ontiveros A, Woc-Colburn L, Bottazzi ME, Rhodes CE, Ballantyne CM, Aguilar D, 2014. Development of Chagas cardiac manifestations among Texas blood donors. Am J Cardiol 115: 113–117.
-
15.
Custer B, Agapova M, Bruhn R, Cusick R, Kamel H, Tomasulo P, Biswas H, Tobler L, Lee TH, Caglioti S, Busch M, 2012. Epidemiologic and laboratory findings from 3 years of testing United States blood donors for Trypanosoma cruzi. Transfusion 52: 1901–1911.
-
16.
Wilson LS, Ramsey JM, Koplowicz YB, Valiente-Banuet L, Motter C, Bertozzi SM, Tobler LH, 2008. Cost-effectiveness of implementation methods for ELISA serology testing of Trypanosoma cruzi in California blood banks. Am J Trop Med Hyg 79: 53–68.
-
17.
Leiby DA, Read EJ, Lenes BA, Yund AJ, Stumpf RJ, Kirchhoff LV, Dodd RY, 1997. Seroepidemiology of Trypanosoma cruzi, etiologic agent of Chagas disease, in US blood donors. J Infect Dis 176: 1047–1052.
-
18.
O'Brien SF, Chiavetta JA, Fan W, Xi G, Yi QL, Goldman M, Scalia V, Fearon MA, 2008. Assessment of a travel question to identify donors with risk of Trypanosoma cruzi: operational validity and field testing. Transfusion 48: 755–761.
-
19.
Garcia MN, Hotez PJ, Murray KO, 2014. Potential novel risk factors for autochthonous and sylvatic transmission of human Chagas disease in the United States. Parasit Vectors 7: 311.
-
20.
Edwards MS, Rench MA, Todd CW, Czaicki N, Steurer FJ, Bern C, Montgomery SP, 2013. Perinatal screening for Chagas disease in southern Texas. J Ped Infect Dis 1–4. Available at: http://jpids.oxfordjournals.org/content/early/2013/10/03/jpids.pit056.1.full.pdf+html?sid=f876a11f-40f5-44d5-91e0-219c6e0f257f.
-
21.
Di Pentima MC, Hwang LY, Skeeter CM, Edwards MS, 1999. Prevalence of antibody to Trypanosoma cruzi in pregnant Hispanic women in Houston. Clin Infect Dis 28: 1281–1285.
-
22.
Stimpert KK, Montgomery SP, 2010. Physician awareness of Chagas disease, USA. Emerg Infect Dis 16: 871–872.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 1162 | 887 | 31 |
| Full Text Views | 652 | 15 | 0 |
| PDF Downloads | 239 | 14 | 0 |